Generic Name : Empagliflozin + Linagliptin Indications Linagliptin is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults. As monotherapy: In patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment. As combination … Read more Pharmacology […]
Generic Name : Empagliflozin Indications Sinjard is indicated in: Pharmacology Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. SGLT2 co-transporters are responsible for reabsorption of glucose from the glomerular filtrate in the kidney. The glucuretic effect resulting from SGLT2 inhibition reduces renal absorption and lowers the renal threshold for glucose, resulting in increased glucose excretion. […]
Product Name : Saroglitazar Saroglitazar is a Dual Peroxisome Proliferator-Activated Receptor (PPAR) of and agonist used for the treatment of Nonalcoholic Fatty Liver Disease (NAFLD), Dyslipidemia and Primary Biliary Cholangitis (PBC). Therapeutic Class Dual Peroxisome Proliferator-Activated Receptor (PPAR) of alpha and gamma agonist Formulation Solid Available Pack Size 3 X 10 Available Strength […]
Generic Name : Rupatadine Fumarate Indications Rupadin is indicated for the symptomatic treatment of Seasonal & Perennial Allergic Rhinitis and Urticaria. Pharmacology Rupatadine is a long-acting, non-sedative antagonist of histamine H1-receptors. It also antagonizes the platelet activating factor (PAF). Both histamine and PAF cause broncho constriction which leads to an increase in the vascular permeability […]
Generic Name:Rituximab Indications Non-Hodgkin’s Lymphoma (NHL): Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent. Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a Rituxim product in combination with chemotherapy, as single-agent maintenance therapy. Non-progressing (including stable […]
Generic Name:Rosuvastatin Indications Resva is indicated in- Pharmacology Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol. Rosuvastatin produces its lipid-modifying effects in two ways. First, it increases the number of hepatic LDL receptors on the cell surface to […]
Generic Name:Pembrolizumab Indications Pemro is a programmed death receptor-1 (PD-1)-blocking antibody indicated: Melanoma: Non-Small Cell Lung Cancer (NSCLC): Small Cell Lung Cancer (SCLC): for the treatment of patients with metastatic SCLC with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Head and Neck Squamous Cell Cancer (HNSCC): […]
Generic Name:Pemetrexed Indications Pemetrex is indicated in Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Limitations of Use: Pemetrex is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer. Mesothelioma: Pemetrex is indicated, in combination with Cisplatin, for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectable or […]
Generic Name:Palonosetron Hydrochloride Indications Paloxi indicated in- Pharmacology Palonosetron is a 5-HT3 receptor antagonist with a strong binding affinity for this receptor and little or no affinity for other receptors. It is thought that chemotherapeutic agents produce nausea and vomiting by releasing serotonin from the enterochromaffin cells of the small intestine and that the released […]
Generic Name:Calcium & Vitamin Indications Calcium and Vitamin D3 is used for the treatment of: To ensure adequate Calcium and Vitamin D3, it may also be used in certain conditions such as: Composition 500 mg & 200 IU: Each film-coated tablet contains Calcium Carbonate BP (eggshell source) 1250 mg equivalent to 500 mg of elemental […]